The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 333:670-671 September 7, 1995 Number 10
NextNext

Marijuana, the AIDS Wasting Syndrome, and the U.S. Government

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Hoover, D. R.
-PubMed Citation
To the Editor: Evidence of the therapeutic value and limited toxicity of marijuana in the treatment of various symptoms and syndromes is rapidly accumulating. Patients with glaucoma, migraine, epilepsy, multiple sclerosis, paraplegia, quadriplegia, the AIDS wasting syndrome, or nausea and vomiting due to chemotherapy for cancer have risked severe penalties to acquire cannabis, because they find it more useful than legally available medicines.1,2 The U.S. government has consistently refused to permit prescription sales of marijuana, insisting that the evidence of its safety and efficacy is inadequate.

In response to a lawsuit brought by advocates of the medical use of marijuana, . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.